Keywords: news, brief, novartis, been, granted, approval, market

News In Brief

Article | 11 December 1997

Print This

- Novartis has been granted US approval to market its new migraineproduct Migranal (dihydroergotamine) in a nasal spray form for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in